Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D): A Multicenter, Randomized, Prospective, Placebo-Controlled, Double-Blind, Phase IV Clinical Study
Sponsor: Lallemand Health Solutions
This PHASE4 trial investigates IBS - Irritable Bowel Syndrome and is currently ongoing. Lallemand Health Solutions leads this study, which shows 7 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Mar 2026 — Present [monthly]
Unknown PHASE4
Status: Recruiting → Unknown
-
Sep 2025 — Mar 2026 [monthly]
Recruiting PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Mar 2024 — Jul 2024 [monthly]
Recruiting PHASE4
▶ Show 2 earlier versions
-
Mar 2023 — Mar 2024 [monthly]
Recruiting PHASE4
-
Sep 2022 — Mar 2023 [monthly]
Recruiting PHASE4
First recorded
Aug 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Lallemand Health Solutions
For direct contact, visit the study record on ClinicalTrials.gov .